MDB Capital Holdings, LLC - Class A common (MDBH)
6.2500
0.00 (0.00%)
MDB Capital Holdings, LLC is a public company that focuses on providing innovative financial solutions, particularly in the technology and biomedical sectors
The company specializes in facilitating capital formation and investment opportunities for early-stage companies by leveraging its expertise in investment banking and venture capital. It aims to bridge the gap between cutting-edge innovation and market access, offering a range of services including advisory, fundraising, and strategic guidance to help its clients navigate the complexities of the financial landscape and achieve sustainable growth. Through its unique approach, MDB Capital Holdings supports the development of transformative technologies and advancements in various industries.
Previous Close | 6.250 |
---|---|
Open | - |
Bid | 6.100 |
Ask | 10.03 |
Day's Range | N/A - N/A |
52 Week Range | 5.780 - 12.00 |
Volume | 0 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 5,232 |
News & Press Releases

•China accounts for 77% of all AI data center patent filings globally, with five of the top patent holders hailing from China - underlining its dominant position in next-generation AI infrastructure
By PatentVest, Inc. · Via GlobeNewswire · March 5, 2025

Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels – today announced that CEO Michael Heltzen will be joined by eXoZymes team members to ring the Nasdaq Stock Market (“Nasdaq”) closing bell on Wednesday, February 19, 2025. This comes following a successful initial public offering of common stock at $8 per share, which closed on November 14, 2024.
By eXoZymes Inc. · Via GlobeNewswire · February 19, 2025

By eXoZymes Inc. · Via GlobeNewswire · February 12, 2025

Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025
By Invizyne Technologies, Inc. · Via GlobeNewswire · February 10, 2025

Addison, TX, Jan. 07, 2025 (GLOBE NEWSWIRE) -- PatentVest, a leader in intellectual property (IP) intelligence and strategy, has released its latest report, “Continuous Glucose Monitoring (CGM): An Evolving Innovation Landscape.” This in-depth analysis explores the rapidly growing CGM market, offering valuable insights into the trends, key players, and opportunities that are shaping the future of diabetes care.
By PatentVest, Inc. · Via GlobeNewswire · January 7, 2025

Management to Host Conference Call Today at 4:30 p.m. ET
By MDB Capital Holdings, LLC · Via GlobeNewswire · November 21, 2024

Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 19, 2024

Addison, Texas, Nov. 15, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQMDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Thursday November 21, 2024 at 4:30 p.m. Eastern Time to discuss its results for the third quarter 2024. A press release detailing these results will be issued prior to the call.
By MDB Capital Holdings, LLC · Via GlobeNewswire · November 15, 2024

Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the closing of its initial public offering of 1,875,000 shares of its common stock at a public offering price of $8.00 per share. The shares began trading on NASDAQ under the ticker symbol “IZTC” on November 13, 2024.
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 14, 2024

Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 13, 2024

Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 13, 2024

Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 12, 2024

Shares to Begin Trading on NASDAQ on November 12, 2024, Under the Ticker Symbol “IZTC”
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 11, 2024

By MDB Capital Holdings, LLC · Via GlobeNewswire · October 16, 2024

MDB Capital Holdings just reported results for the second quarter of 2024.
Via InvestorPlace · August 13, 2024
By MDB Capital Holdings, LLC · Via GlobeNewswire · July 11, 2024

By PatentVest, Inc. · Via GlobeNewswire · July 9, 2024
Addison, Texas, June 20, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQMDBH) (“MDB Capital”), a public venture platform focused on launching category-leading deep technology companies, today announced the appointment of Daniel Torpey to its Board of Directors, effective June 17, 2024.
By MDB Capital Holdings, LLC · Via GlobeNewswire · June 20, 2024

By PatentVest, Inc. · Via GlobeNewswire · May 22, 2024
Addison, TX, May 22, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQMDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announces its self-clearing broker dealer and associated online and mobile trading platforms will now unify under one brand name, MDB Capital.
By MDB Capital Holdings, LLC · Via GlobeNewswire · May 22, 2024

MDB Capital Holdings just reported results for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

By Invizyne Technologies, Inc. · Via GlobeNewswire · May 7, 2024

Management to Host Zoom Webinar Today at 4:30 p.m. ET
By MDB Capital Holdings, LLC · Via GlobeNewswire · April 17, 2024

Addison, Texas, April 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQMDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, plans to host a Zoom webinar on Wednesday April 17, 2024 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full fiscal year ended December 31, 2023. A press release detailing these results will be issued prior to the call.
By MDB Capital Holdings, LLC · Via GlobeNewswire · April 11, 2024

MDB Capital Holdings just reported results for the fourth quarter of 2023.
Via InvestorPlace · April 2, 2024